In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19

Affiliations

¹ University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana.
³ The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁴ University of Verona, Verona, Italy.

Comment

Fabian Sanchis-Gomar et al. Mayo Clin Proc. 2020 Nov.

. 2020 Nov;95(11):2561-2563.

doi: 10.1016/j.mayocp.2020.09.011. Epub 2020 Sep 14.

¹ University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana.
³ The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁴ University of Verona, Verona, Italy.

No abstract available

Comment on

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.
Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Sanchis-Gomar F, et al. Mayo Clin Proc. 2020 Jun;95(6):1222-1230. doi: 10.1016/j.mayocp.2020.03.026. Epub 2020 Apr 4. Mayo Clin Proc. 2020. PMID: 32376099 Free PMC article. Review.
Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19.
Garg A, Rout A, Sharma A, Fiorello B, Kostis JB. Garg A, et al. Mayo Clin Proc. 2020 Nov;95(11):2559-2561. doi: 10.1016/j.mayocp.2020.09.010. Epub 2020 Sep 14. Mayo Clin Proc. 2020. PMID: 33153642 Free PMC article. No abstract available.

1. Sanchis-Gomar F., Lavie C.J., Perez-Quilis C., Henry B.M., Lippi G. In Reply - angiotensin-converting enzyme 2 and the resolution of inflammation: in support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers. Mayo Clin Proc. 2020;95(7):1553–1556. - PMC - PubMed
1. Sanchis-Gomar F., Lavie C.J., Perez-Quilis C., Henry B.M., Lippi G. Angiotensin-converting enzyme 2 and anti-hypertensives (angiotensin receptor blockers and angiotensin converting enzyme inhibitors) in coronavirus disease 2019 (COVID-19) Mayo Clin Proc. 2020;95(6):1222–1230. - PMC - PubMed
1. Garg A., Rout A., Sharma A., Fiorello B., Kostis J.B. Association of renin angiotensin system blockers with outcomes in patients with COVID-19. Mayo Clin Proc. 2020 doi: 10.1016/jmayocp.2020.09.010. [Epub ahead of print] - DOI - PMC - PubMed
1. Lopez-Otero D., Lopez-Pais J., Cacho-Antonio C.E. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry. Rev Esp Cardiol (Engl Ed) 2020 doi: 10.1016/j.rec.2020.1005.1018. [Epub ahead of print] - DOI - PMC - PubMed
1. Iaccarino G., Grassi G., Borghi C. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366–372. - PubMed